Hartford Healthcare Cancer Institute at Hartford Hospital

Hartford, Connecticut 06106

2 studies enrolling now · 7 studies all time

What they study most

Cancer, Castration-Resistant Prostatic Cancer, Cervical Cancer, Endometrial Cancer, Hepatocellular Carcinoma, Metastatic Castration-resistant Prostate Cancer, Neoplasms

Studies at this site

• A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer — Recruiting now
• A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer — Recruiting now
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) — Running, not enrolling
• A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis — Running, not enrolling
• A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) — Running, not enrolling
• Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) — TEMPORARILY_NOT_AVAILABLE
• The Circulating Cell-free Genome Atlas Study — Status unconfirmed